← FDA Drug Approvals (Drugs@FDA)
LAMIVUDINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BRECKENRIDGE · Approved 2016-11-21
Drug application
- FDA Application #
ANDA203586- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- LAMIVUDINE
- Generic name
- Lamivudine
- Active ingredients
- LAMIVUDINE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- BRECKENRIDGE
- First approval
- 2016-11-21
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown